EMA Authorised: Nordimet (methotrexate) — Nordic Group B.V.

View source ↗

Summary

EMA authorised Nordimet (methotrexate) by Nordic Group B.V. for use in arthritis-related conditions including rheumatoid arthritis, psoriatic arthritis, psorias…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Nordimet (methotrexate)

Snippet

Status: Authorised. Therapeutic area: Arthritis, Psoriatic;Psoriasis;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid. MAH: Nordic Group B.V.. Decision date: 15/07/2025